ATE286736T1 - Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin - Google Patents

Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin

Info

Publication number: ATE286736T1
Authority: AT; Austria
Prior art keywords: clarithromycin; compressable; matrix; direct; daily doses
Prior art date: 1999-02-19

Application number

AT00905514T

Other languages

English (en)

Inventor

Temeljotov Darja Fercej

Milojka Mohar

Mateja Salobir

Ljubomira Barbara Rebic

Marko Opresnik

Original Assignee

Lek Farmacevtska Druzba Dd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-19

Filing date

2000-02-17

Publication date

2005-01-15

2000-02-17 Application filed by Lek Farmacevtska Druzba Dd filed Critical Lek Farmacevtska Druzba Dd

2005-01-15 Application granted granted Critical

2005-01-15 Publication of ATE286736T1 publication Critical patent/ATE286736T1/de

Links

AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 title abstract 2
229960002626 clarithromycin Drugs 0.000 title abstract 2
239000011159 matrix material Substances 0.000 title abstract 2
239000013543 active substance Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT00905514T 1999-02-19 2000-02-17 Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin ATE286736T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SI9900039A SI20150A (sl)	1999-02-19	1999-02-19	Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
PCT/SI2000/000002 WO2000048607A1 (en)	1999-02-19	2000-02-17	Directly compressible matrix for controlled release of single daily doses of clarithromycin

Publications (1)

Publication Number	Publication Date
ATE286736T1 true ATE286736T1 (de)	2005-01-15

Family

ID=20432410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00905514T ATE286736T1 (de)	1999-02-19	2000-02-17	Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin

Country Status (21)

Country	Link
EP (1)	EP1150686B1 (de)
AT (1)	ATE286736T1 (de)
AU (1)	AU776912B2 (de)
BG (1)	BG65324B1 (de)
CY (1)	CY1107454T1 (de)
CZ (1)	CZ302781B6 (de)
DE (1)	DE60017361T2 (de)
DK (1)	DK1150686T3 (de)
EE (1)	EE05422B1 (de)
ES (1)	ES2235834T3 (de)
HR (1)	HRP20010684B1 (de)
HU (1)	HUP0105481A3 (de)
PL (1)	PL196665B1 (de)
PT (1)	PT1150686E (de)
RS (1)	RS50298B (de)
RU (1)	RU2237480C2 (de)
SI (2)	SI20150A (de)
SK (1)	SK287525B6 (de)
TR (1)	TR200102396T2 (de)
UA (1)	UA74778C2 (de)
WO (1)	WO2000048607A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200000054A2 (tr) *	2000-01-05	2001-08-21	Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇	Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
IN192748B (de) *	2000-08-29	2004-05-15	Ranbaxy Lab Ltd
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US6673369B2 (en)	2001-08-29	2004-01-06	Ranbaxy Laboratories Limited	Controlled release formulation
US6642276B2 (en) *	2001-10-01	2003-11-04	M/S Ind-Swift Limited	Controlled release macrolide pharmaceutical formulations
SE0103369D0 (sv) *	2001-10-09	2001-10-09	Astrazeneca Ab	Pharmaceutical formulation
EP1443910A1 (de)	2001-11-02	2004-08-11	Wockhardt Limited	Zubereitungen mit kontrollierter freigabe von makrolidantibiotika
BR0308989A (pt) *	2002-04-03	2005-01-04	Ranbaxy Lab Ltd	Formulações de claritromicina com biodisponibilidade aperfeiçoada e processo de preparação das mesmas
US20060083759A1 (en) *	2002-07-17	2006-04-20	Aleksander Resman	Stabilization of the profile of release of active substances from a formulation
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1534238A1 (de) *	2002-07-29	2005-06-01	ALZA Corporation	Formulierungen und dosierformen fuer die kontrollierte abgabe von topiramat
AU2004264356B2 (en)	2003-08-12	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
WO2005023221A1 (en) *	2003-09-05	2005-03-17	Ranbaxy Laboratories Limited	Clarithromycin formulations having improved biovailability
RU2268051C2 (ru) *	2003-12-15	2006-01-20	Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское"	Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
US7943585B2 (en) *	2003-12-22	2011-05-17	Sandoz, Inc.	Extended release antibiotic composition
EP1732518A1 (de) *	2004-03-24	2006-12-20	Lupin Ltd.	Clarithromycin-formulierung mit verlängerter freisetzung
EP2283824B1 (de)	2009-07-30	2017-04-19	Special Products Line S.p.A.	Zusammensetzungen und Formulierungen, die auf quellbaren Matrizen basieren, zur verzögerten Freisetzung von schlecht löslichen Arzneimitteln, wie zum Beispiel Clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4331803A (en) *	1980-06-04	1982-05-25	Taisho Pharmaceutical Co., Ltd.	Novel erythromycin compounds
JPS60163823A (ja) *	1984-02-03	1985-08-26	Taisho Pharmaceut Co Ltd	経口投与製剤
JPS60214796A (ja) *	1984-04-06	1985-10-28	Taisho Pharmaceut Co Ltd	６−０−メチルエリスロマイシン類の製法
JPS63188621A (ja) *	1987-01-30	1988-08-04	Taisho Pharmaceut Co Ltd	矯味経口製剤
US4808411A (en) *	1987-06-05	1989-02-28	Abbott Laboratories	Antibiotic-polymer compositions
IL87219A0 (en) *	1987-08-07	1988-12-30	Abbott Lab	Erythromycin formulations for oral administration
JP2553882B2 (ja) *	1987-08-08	1996-11-13	富士写真光機株式会社	走査結像光学系
US5599556A (en) *	1991-12-31	1997-02-04	Abbott Laboratories	Prolamine coatings for taste masking
DE69530973T2 (de) *	1994-02-16	2004-05-19	Abbott Laboratories, Abbott Park	Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen

1999
- 1999-02-19 SI SI9900039A patent/SI20150A/sl not_active IP Right Cessation
2000
- 2000-02-17 UA UA2001096230A patent/UA74778C2/uk unknown
- 2000-02-17 HU HU0105481A patent/HUP0105481A3/hu unknown
- 2000-02-17 AT AT00905514T patent/ATE286736T1/de active
- 2000-02-17 EP EP00905514A patent/EP1150686B1/de not_active Expired - Lifetime
- 2000-02-17 AU AU27049/00A patent/AU776912B2/en not_active Ceased
- 2000-02-17 PL PL350419A patent/PL196665B1/pl unknown
- 2000-02-17 CZ CZ20012964A patent/CZ302781B6/cs not_active IP Right Cessation
- 2000-02-17 SK SK1197-2001A patent/SK287525B6/sk not_active IP Right Cessation
- 2000-02-17 WO PCT/SI2000/000002 patent/WO2000048607A1/en not_active Ceased
- 2000-02-17 HR HR20010684A patent/HRP20010684B1/xx not_active IP Right Cessation
- 2000-02-17 RS YUP-592/01A patent/RS50298B/sr unknown
- 2000-02-17 SI SI200030647T patent/SI1150686T1/xx unknown
- 2000-02-17 DE DE60017361T patent/DE60017361T2/de not_active Expired - Lifetime
- 2000-02-17 DK DK00905514T patent/DK1150686T3/da active
- 2000-02-17 RU RU2001125667A patent/RU2237480C2/ru not_active IP Right Cessation
- 2000-02-17 TR TR2001/02396T patent/TR200102396T2/xx unknown
- 2000-02-17 ES ES00905514T patent/ES2235834T3/es not_active Expired - Lifetime
- 2000-02-17 PT PT00905514T patent/PT1150686E/pt unknown
- 2000-02-17 EE EEP200100433A patent/EE05422B1/xx not_active IP Right Cessation
2001
- 2001-09-19 BG BG105914A patent/BG65324B1/bg unknown
2005
- 2005-03-10 CY CY20051100330T patent/CY1107454T1/el unknown

Also Published As

Publication number	Publication date
TR200102396T2 (tr)	2002-01-21
SK11972001A3 (sk)	2002-02-05
HRP20010684A2 (en)	2002-10-31
EE200100433A (et)	2002-12-16
PL196665B1 (pl)	2008-01-31
HRP20010684B1 (hr)	2011-01-31
BG105914A (bg)	2002-05-31
CZ302781B6 (cs)	2011-11-02
AU2704900A (en)	2000-09-04
EP1150686B1 (de)	2005-01-12
PT1150686E (pt)	2005-05-31
UA74778C2 (en)	2006-02-15
SK287525B6 (sk)	2011-01-04
ES2235834T3 (es)	2005-07-16
RU2237480C2 (ru)	2004-10-10
EE05422B1 (et)	2011-06-15
SI20150A (sl)	2000-08-31
AU776912B2 (en)	2004-09-23
DE60017361T2 (de)	2005-12-22
CY1107454T1 (el)	2012-12-19
PL350419A1 (en)	2002-12-16
HUP0105481A2 (hu)	2002-05-29
HUP0105481A3 (en)	2003-04-28
CZ20012964A3 (cs)	2002-01-16
DK1150686T3 (da)	2005-04-04
DE60017361D1 (de)	2005-02-17
EP1150686A1 (de)	2001-11-07
RS50298B (sr)	2009-09-08
WO2000048607A1 (en)	2000-08-24
SI1150686T1 (en)	2005-06-30
BG65324B1 (bg)	2008-02-29
YU59201A (sh)	2004-07-15

Legal Events

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1150686

Country of ref document: EP

Publication	Publication Date	Title
DE60017361D1 (de)	2005-02-17	Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
SV2004001556A (es)	2004-03-08	Preparaciones acidas de insulina con establidad mejorada
NO20011721D0 (no)	2001-04-05	N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
HUP9900301A2 (hu)	1999-06-28	Hormontapasz
AU2002223684A1 (en)	2002-06-03	Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
NO20025621D0 (no)	2002-11-22	Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
AU2001296865A1 (en)	2002-03-22	(5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
DE60019334D1 (de)	2005-05-12	Antivirale arznei
GT200900154A (es)	2012-01-17	Derivados de 2,3-dihidroimidozo [1,2-c] quinizolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
BR0111678A (pt)	2003-06-03	Composições medicinais contendo derivados de propenona
WO2001010425A3 (de)	2002-02-07	Verwendung von cgrp-antagonisten und cgrp-release-hemmern zur bekämpfung menopausaler hitzewallungen
ECSP930933A (es)	1994-04-20	Composicion farmaceutica y procedimiento para prepararla
DK1171101T3 (da)	2007-07-16	Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
WO2005065639A3 (en)	2005-09-01	Novel pharmaceutical compositions
DE50115451D1 (de)	2010-06-02	Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
BR0212467A (pt)	2004-10-19	Procedimento de preparação dos ácidos hidróxigraxos insaturados e de seus ésteres, sua utilização em preparações farmacêuticas e/ou cosméticas
BR0015422B1 (pt)	2012-09-04	formulações de droga de liberação prolongada.
BR0202759A (pt)	2004-05-11	Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
AR005730A1 (es)	1999-07-14	Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
HUP0202888A2 (hu)	2002-12-28	Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
SE9902674D0 (sv)	1999-07-12	New composition
UA34406A (uk)	2001-02-15	Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка